You just read:

Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency

News provided by

Synageva BioPharma Corp.

30 Jun, 2014, 21:02 BST